vinpocetine has been researched along with Ischemic Stroke in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Panda, P; Panda, PK; Ramachandran, A; Sharawat, IK | 1 |
| Cao, W; Fan, C; Guo, X; Hou, B; Jiang, C; Li, D; Ren, H; Wan, Z; Wang, D; Wang, G; Yan, G; Zhao, L | 1 |
| Gao, Y; Han, D; Liu, H; Sun, M; Wang, J; Wen, L | 1 |
1 review(s) available for vinpocetine and Ischemic Stroke
| Article | Year |
|---|---|
Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Topics: Humans; Ischemic Stroke; Neuroprotective Agents; Randomized Controlled Trials as Topic; Stroke; Vinca Alkaloids | 2022 |
2 other study(ies) available for vinpocetine and Ischemic Stroke
| Article | Year |
|---|---|
Neuroprotective Effects of Vinpocetine Against Ischemia-Reperfusion Injury Via Inhibiting NLRP3 Inflammasome Signaling Pathway.
Topics: Animals; Brain Ischemia; Infarction, Middle Cerebral Artery; Inflammasomes; Ischemic Stroke; Mice; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Reperfusion Injury; Signal Transduction; Sulfonamides | 2023 |
Vinpocetine Attenuates Ischemic Stroke Through Inhibiting NLRP3 Inflammasome Expression in Mice.
Topics: Animals; Anti-Inflammatory Agents; Brain; Disease Models, Animal; Infarction, Middle Cerebral Artery; Inflammasomes; Inflammation Mediators; Interleukin-18; Interleukin-1beta; Ischemic Stroke; Male; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Vinca Alkaloids | 2020 |